Characterizing the Developmental Trajectory of Sirolimus Clearance in Neonates and Infants-Reference-Cited by-同舟云学术

Characterizing the Developmental Trajectory of Sirolimus Clearance in Neonates and Infants

Published:2016-08 Issue:8 Volume:5 Page:411-417
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Emoto C¹²,Fukuda T¹²,Mizuno T¹,Schniedewind B³,Christians Uwe³,Adams DM²⁴,Vinks AA¹²

Affiliation:

1. Division of Clinical PharmacologyCincinnati Children's Hospital Medical CenterCincinnati Ohio USA

2. Department of PediatricsUniversity of Cincinnati College of MedicineCincinnati Ohio USA

3. iC42 Integrated Solutions in Clinical Research and Development, University of Colorado, Anschutz Medical CenterAurora Colorado USA

4. Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical CenterCincinnati Ohio USA

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12096

Reference40 articles.

1. Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus

2. Sirolimus for the treatment of complicated vascular anomalies in children

3. A Phase 2 Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas (NCT00634270). 2008 March 14 2014 [cited] Available from:

4. A Phase 2 Study — Clinical Trial Assessing Efficacy and Safety of the mTOR Inhibitor Sirolimus in the Treatment of Complicated Vascular Anomalies (NCT00975819). 2009 [cited] Available from:

5. Tips and traps analyzing pediatric PK data

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-Informed individualized dosage regimen of sirolimus in pediatric patients with intractable lymphatic malformations;European Journal of Pharmaceutical Sciences;2024-09

2. Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results;Annals of the Child Neurology Society;2024-04-22

3. Cardiac Rhabdomyomas Presenting with Critical Cardiac Obstruction in Neonates and Infants: Treatment Strategies and Outcome, A Single-Center Experience;Pediatric Cardiology;2024-03-13

4. Sirolimus for vascular anomalies in the first year of life: a systematic review;Journal of Perinatology;2024-01-20

5. Case report: Accelerated regression of giant cardiac rhabdomyomas in neonates with low dose everolimus;Frontiers in Pediatrics;2023-02-15